Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
Abstract Background In order to utilize polygenic risk scores (PRSs) for Alzheimer’s disease (AD) in a meaningful way, influential factors (i.e. training set) and prediction across groups such as APOE e4 (APOE4) genotype as well as associations to dementia-related biomarkers should be explored. Ther...
Main Authors: | Hannah Stocker, Kira Trares, Léon Beyer, Laura Perna, Dan Rujescu, Bernd Holleczek, Konrad Beyreuther, Klaus Gerwert, Ben Schöttker, Hermann Brenner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-023-01277-8 |
Similar Items
-
Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer’s disease and vascular dementia in a prospective study
by: Kira Trares, et al.
Published: (2024-04-01) -
Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
by: Jenna Najar, et al.
Published: (2021-01-01) -
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
by: Thi Ngoc Mai Nguyen, et al.
Published: (2022-05-01) -
Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease
by: Tobias Möllers, et al.
Published: (2021-01-01) -
Polygenic effects on the risk of Alzheimer’s disease in the Japanese population
by: Masataka Kikuchi, et al.
Published: (2024-02-01)